Skip to main content
. 2023 Apr 7;5(7):100753. doi: 10.1016/j.jhepr.2023.100753

Table 3.

Diagnostic accuracy results of NITs compared with MRS.

MRS
US
Conventional CAP according to EASL
CAP determined by Youden index
Conventional FLI
FLI determined by Youden index
US + CAP
US + FLI
N 132 132 127 127 132 132 131 132
AUROC Ref. 0.98 0.85 0.85 0.83 0.83 0.93 0.93
Cut-off Ref. ≥1 criterion >275 dB/m ≥270 dB/m ≥60 ≥45 US ≥1 criterion and CAP ≥270 dB/m US ≥1 criterion and FLI ≥45
NAFLD prevalence, N (%) 21 (15.9) 25 (18.9) 43 (33.9) 46 (36.2) 37 (28.0) 59 (44.7) 21 (16.0) 23 (17.4)
Sensitivity Ref. 1.00 0.80 0.90 0.62 0.91 0.91 0.91
Specificity Ref. 0.96 0.75 0.74 0.78 0.64 0.98 0.96
PPV Ref. 0.84 0.37 0.39 0.35 0.32 0.91 0.83
NPV Ref. 1.00 0.95 0.98 0.92 0.97 0.98 0.98
+LR Ref. 25 3.20 3.46 2.81 2.53 45.5 22.8
-LR Ref. 0.001 0.27 0.14 0.48 0.14 0.91 0.09

Accuracy analysis of NITs compared with MRS >5.56%. Conventional CAP and FLI cut-offs according to current EASL guidelines. Prevalence shown as N (%). Cut-off determined by Youden’s index (sensitivity + specificity - 1). Diagnostic indices shown as percentages. The significance level was set at p <0.05.

AUROC, area under receiver-operator curve; CAP, controlled attenuation parameter; FLI, fatty liver index; +LR, positive likelihood ratio; -LR, negative likelihood ratio; MRS, (1H) magnetic resonance spectroscopy; NITs, non-invasive tests; NPV, negative predictive value; PPV, positive predictive value; US, ultrasound.

One subject had a positive US, but failed VCTE.

Equation performed with sensitivity of 0.999.